help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2003-0537
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
144/11/4923    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monjo, M.
Right arrow Articles by Roca, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monjo, M.
Right arrow Articles by Roca, P.
Endocrinology Vol. 144, No. 11 4923-4930
Copyright © 2003 by The Endocrine Society

Direct Effects of Testosterone, 17ß-Estradiol, and Progesterone on Adrenergic Regulation in Cultured Brown Adipocytes: Potential Mechanism for Gender-Dependent Thermogenesis

Marta Monjo, Ana M. Rodríguez, Andreu Palou and Pilar Roca

Laboratori de Bioquímica i Biologia Molecular, Departament de Biologia Fonamental i Ciències de la Salut, Universitat de les Illes Balears, Palma de Mallorca 07071, Spain

Address all correspondence and requests for reprints to: Pilar Roca, Departament de Biologia Fonamental i Ciències de la Salut, Edifici Guillem Colom, Universitat de les Illes Balears, Carretera Valldemossa, Km 7.5, Palma de Mallorca 07071, Spain. E-mail: pilar.roca{at}uib.es.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Previous studies suggest that sex hormones could be responsible, at least in part, for the gender-dependent thermogenesis found in the adrenergic control of brown adipose tissue (BAT) under control conditions and in response to diet and cold. Catecholamines, as well as several hormones, including sex hormones, may alter the function or expression of different adrenoceptor subtypes in brown adipocytes in vivo, and a confirmation could be provided by in vitro experiments. Therefore, the effect of testosterone, 17ß-estradiol, progesterone, and norepinephrine (NE) on adrenergic receptor (AR) gene expression ({alpha}2A-, ß1-, ß2-, and ß3-AR) and lipolytic activity was investigated in differentiated brown adipocytes in culture. We report that the expression of each AR subtype gene was distinctively regulated by NE and sex hormones in brown adipocytes. Testosterone-treated cells had lower lipolytic activity and increased expression of antilipolytic receptors {alpha}2A-AR. Both 17ß-estradiol and progesterone decreased {alpha}2A-AR expression and {alpha}2A3-AR protein ratio, but progesterone had higher potency than 17ß-estradiol, increasing ß-AR levels, mainly ß3-AR expression, and enhancing lipolysis stimulated by NE. In conclusion, our results support the idea that male and female sex hormones, as a part of the hormonal environment of BAT, have direct and opposite effects on the AR balance and lipolytic activity, and they might play a role in the gender dimorphism for the recruitment process in BAT.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
IN RODENTS, BROWN ADIPOSE tissue (BAT) is the main effector of adaptive thermogenesis, also referred to as facultative thermogenesis, which is defined as heat production, protecting the organism from cold exposure and avoiding weight gain by regulating energy balance (1). Heat production by BAT is brought about by uncoupling protein 1 (UCP1), which is expressed mainly in this tissue, and is under control of the sympathetic nervous system through adrenergic receptors (ARs) (2). It is well established that different adrenoceptor subtypes coexist in adipocytes and that ß-ARs (ß1, ß2, and ß3) increase cAMP levels, whereas {alpha}2A-AR decreases cAMP levels (3). ß3-AR is known to be quantitatively the most abundant ß-AR in brown adipocytes (4), and {alpha}2A-AR is also highly expressed in these cells (5). The {alpha}2A3-AR ratio is key in the regulation of thermogenesis and lipolysis (6, 7), through regulation of cAMP levels, which controls both UCP1 expression (2, 8) and the release of free fatty acids, which are positive UCP1 modulators (5). Thus, a lower {alpha}2A3-AR ratio would lead to a greater thermogenic activity and lipolysis, and vice versa.

The recruitment process in BAT is the basis for the enhancement of the thermogenic capacity in rodents adapted to cold and certain diets, and it includes proliferation from precursor cells within this tissue, differentiation of these cells into mature brown adipocytes, and mitochondriogenesis to provide thermogenic mitochondria, together with an increased UCP1 expression (9). Gender dimorphism has been established in the morphology, thermogenesis function and adrenergic response in BAT (7), and gender differences have also been found in the thermogenic response of this tissue to overfeeding, overweight, and cold (6, 10, 11, 12). As a consequence, sex hormones have been proposed as key factors that could explain, at least in part, the gender differences observed in the recruitment of BAT. However, it is not known whether sex hormones exert their effect through an indirect mechanism or directly at the adipocyte level. The existence of sex hormone receptors in adipocytes (13, 14, 15) would argue for a direct effect in the adipocyte, and in vitro methodology offers a powerful approach for the confirmation of such hypotheses.

We have recently reported, in primary cultures of brown adipocytes, distinct actions of testosterone, progesterone, and 17ß-estradiol on UCP1 expression and lipid accumulation (12). Nevertheless, it is not known whether these effects could be mediated via the modulation of the activity or the expression of {alpha}2A- and ß-adrenoceptors.

Moreover, ARs are thought to be affected by sex hormones in brown adipocytes, because {alpha}2A- and ß-ARs have been previously observed to show a gender dimorphism in BAT (6, 7). Therefore, whether the adrenergic regulation observed in vivo could be attributed to a direct effect of the sex hormones on the brown adipocytes is one of the questions that remain to be resolved.

The aim of this study was to investigate, under cell culture conditions, the direct effects of testosterone, 17ß-estradiol, and progesterone on the expression of ARs and lipolytic activity in male differentiated brown adipocytes. Moreover, norepinephrine (NE) regulation of gene expression for the different adrenoceptor subtypes was further characterized in this model by showing a specific regulation for each subtype. We find that in vitro sex hormones modulate distinctively AR expression for the different subtypes by a transcriptional mechanism and regulate lipolytic activity in differentiated brown adipocytes. Furthermore, the male and female sex hormones showed opposite effects regulating adrenoceptor expression and lipolysis. Thus, our findings provide support for the idea that sex hormones, as a part of the hormonal environment, might play a role in the recruitment process of BAT.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Materials
Testosterone, 17ß-estradiol, progesterone, and flutamide were from Sigma (St. Louis, MO), ICI 182.780 was from Tocris (Bristol, UK), and Mifepristone (RU486) was from Biomol (Plymouth, PA). Other cell culture reagents were supplied by Sigma and Invitrogen (Barcelona, Spain), and routine chemicals were from Merck (Barcelona, Spain) and Panreac (Barcelona, Spain).

Cell isolation, culture, and treatments
Brown fat precursor cells were isolated, as previously described (16), from 4-wk-old male NMRI mice (obtained from CRIFFA, Barcelona, Spain) and were cultured as described in Ref.12 . All animals were treated in accord with the principles and procedures outlined in the Guidelines for Care and Use of Experimental Animals. The cultured medium was DMEM, supplemented with 10% newborn calf serum, 4 nM insulin, 4 mM glutamine, antibiotics (50 IU penicillin/ml and 50 µg streptomycin/ml), 10 mM HEPES, and 25 µg sodium ascorbate/ml. This medium-containing serum was changed on d 1 (cells were previously washed with DMEM) and d 3. On d 6, the medium was discarded, and a serum-free medium was added, consisting of DMEM-F12 (1:1), free fatty acid BSA (0.5%), 4 nM insulin, 4 mM glutamine, antibiotics (50 IU penicillin/ml and 50 µg streptomycin/ml), 10 mM HEPES, and 25 µg sodium ascorbate/ml.

The different treatments were carried out on d 6, when cells presented a differentiated morphology and important lipid accumulation, and when they were placed in the serum-free medium to avoid hormonal interference due to the serum. Steroid hormones and inhibitors of steroid hormones were dissolved in ethanol (testosterone, 17ß-estradiol, progesterone, or flutamide) or dimethylsulfoxide (DMSO) (ICI 182.780 or RU486) and added to the corresponding flasks, never exceeding a final ethanol or DMSO concentration of 0.01%. An equivalent volume of ethanol or DMSO was added in untreated controls. On d 7, after 24 h treatment, without changing the medium, the cells were exposed to NE for 6 h. Then, an aliquot of the medium was taken for measurement of glycerol released, the medium was discarded, and the cells were harvested with a monophasic solution of phenol and guanidine thiocyanate (Roche Diagnostics, Mannheim, Germany) for isolation of RNA, DNA, and protein.

RNA, DNA, and protein isolation
Total RNA, DNA, and protein were isolated following the instructions of the manufacturer. RNA and DNA were determined using a spectrophotometer set at 260 nm. Proteins were determined using a bicinchoninic acid protein assay kit (Pierce, Rockford, IL).

RT-PCR analysis
For semiquantitative RT-PCR analysis of ß1-, ß2-, ß3-, and {alpha}2A-AR, 0.5 µg of the total RNA was reverse transcribed to cDNA at 42 C for 60 min with 25 U MuLV reverse transcriptase in a 10-µl vol of reverse transcriptase reaction mixture containing 10 mM Tris-HCl (pH 9.0 at 25 C), 50 mM KCl, 0.1% Triton X-100, 2.5 mM MgCl2, 2.5 µM random hexamers, 10 U ribonuclease inhibitor, and 500 µM each deoxynucleotide triphosphate. cDNAs were denatured for 30 sec at 95 C and submitted to 30 amplification cycles. One PCR cycle consisted of 20 sec at 95 C, 20 sec at 60 C, and 30 sec at 72 C, followed by a final extension of 7 min at 72 C in a DNA thermal cycler 2400 (Applied Biosystems, Madrid, Spain). PCRs were performed in a final vol of 25 µl containing 10 µl cDNA, 10 mM Tris-HCl (pH 9.0 at 25 C), 50 mM KCl and 0.1% Triton X-100, 1.2 mM MgCl2, 1.25 U Taq polymerase, and 200 nM of both sense and antisense primers for adrenoceptors and 20 nM of both sense and antisense primers for ß-actin, which was used as the control of amplification.

The reliability of the RT-PCR assay as a semiquantitative tool was evaluated by testing the linearity of the reaction, relative to cycle number. The amplification reaction was essentially linear up to 30 cycles for ß1-AR, ß2-AR, ß3-AR, {alpha}2A-AR, and the coamplified control ß-actin.

Sequences of the sense and antisense oligonucleotides were as follows: 5'-TCGTGTGCACAGTGTGGGCC-3' and 5'-AAGCGGCGCTCGCAGCTGTCGATC-3' for ß1-AR; 5'-GTGTTGTGCGTCACAGCCAG-3' and 5'-CCTCCCATCCTG-CTCCACCT-3' for ß2-AR; 5'-TAGTCCTGGTGTGGATCGTGTCCGC-3' and 5'-GCGATGAAAACTCCGCTGG-GAACTA-3' for ß3-AR; 5'-GCGCCCCAGAACCTCTTCCTGGTG-3' and 5'-GAGTGGC-GGGAAGGAGATGACGGC-3' for {alpha}2A-AR; 5'-ACGGGCATTGTGATGGACTC-3' and 5'-GTGGTGGTGAAGCTGTAGCC-3' for ß-actin. These primers were derived from the sequences of the corresponding genes and cDNAs. Amplification products had the expected sizes of 265, 420, 514, 311, and 145 bp for ß1-, ß2-, ß3-, {alpha}2A-AR, and ß-actin, respectively.

The resulting PCR products were separated on a 2% agarose gel in 45 mM Tris-Borate-1 mM EDTA Buffer (pH 8.0) and visualized by ethidium bromide. PCR products were analyzed by video-densitometric scanning and quantified using the KODAK 1D Image Analysis Software 3.5 (Eastman Kodak Co., Rochester, NY). Levels of mRNA were expressed as the ratio of signal intensity for the target genes relative to that for ß-actin.

Western-blot analysis
Fifteen micrograms of total protein were fractionated by SDS-PAGE on 10% polyacrylamide gels according to Laemmli (17) and electrotransferred onto a nitrocellulose filter as described elsewhere (18). Ponceau S staining provided visual evidence for correct loading and electrophoretic transfer of proteins to the nitrocellulose filter. Blocking and development of the immunoblots were performed using an enhanced chemiluminescence Western blotting analysis system (Amersham, Barcelona, Spain). Polyclonal antibodies against {alpha}2A- and ß3-AR (Santa Cruz Biotechnology, Santa Cruz, CA) were used as primary antibodies. Autoradiograms of membrane revealed proteins with apparent molecular masses of 58 and 55 kDa, for ß3- and {alpha}2A-AR, respectively.

Bands in films were analyzed by scanner photodensitometry and quantified using the KODAK 1D Image Analysis Software 3.5 (Eastman Kodak Co.).

Measurement of lipolysis
On d 7, after 24 h treatment with sex hormones, brown adipocyte cultures were incubated for 6 h in the absence or presence of NE, without changing the medium, and lipolysis was monitored as the amount of glycerol released into the medium. Glycerol was determined enzymatically with a Sigma Chemical kit [Triglyceride (GPO-Trinder) no. 337]. The DNA content was determined as described above, and glycerol release was corrected per microgram of cell DNA. The results were expressed as a percentage of the values obtained in samples not incubated with hormones or NE, which were set at 100%.

Statistics
All data are presented as mean values ± SEM. Differences between groups were assessed by one-way ANOVA and Student’s t test for post hoc comparisons, using a statistical software package (SPSS, Inc., Chicago, IL).

In the ANOVA, possible effects are: effect of testosterone treatment, effect of 17ß-estradiol, effect of progesterone, and effect of NE. Results were considered statistically significant at the P < 0.05 level.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Previous work in our laboratory has confirmed, that mouse brown preadipocytes differentiate in serum-containing medium after 6 d in primary culture, when the medium was changed for another that was free of serum for 24 h, to avoid the hormonal influence. In these conditions, cells show a differentiated morphology, with marked accumulation of lipids, and express UCP1 under 6 h adrenergic stimulation, which is a differentiation marker of brown adipocytes (12). At this point of differentiation, all ß-AR subtypes and also {alpha}2A-AR were expressed in brown adipocytes. Other authors have described an apparent absence of ß2-AR expression, using Northern-blot analysis in a similar model (19). However, it is possible that the discrepancy with our results could be attributed to the lower sensitivity of Northern-blot compared with RT-PCR.

Differential effect of NE concentration on AR gene expression
Adrenergic receptor gene expression is known to be modulated by NE and to depend both on the receptor subtype and the cell type (19). The effects of NE concentration, i.e. 10-8, 10-7, 10-6, and 10-5 M, on ß1-, ß2-, ß3-, and {alpha}2A-AR mRNA levels and ß3- and {alpha}2A-AR protein levels are shown in Fig. 1Go. ß1-AR mRNA levels were up-regulated by NE at all doses used, whereas ß3-AR showed an important dose-dependent down-regulation; both results are in accordance with earlier observations by other authors (19, 20, 21). The {alpha}2A-AR and ß2-AR mRNA levels showed a dose-dependent down-regulation, more moderate than ß3-AR, which was statistically significant at the highest doses of NE, i.e. 10-6 and 10-5 M.



View larger version (27K):
[in this window]
[in a new window]
 
FIG. 1. Dose-response curves for the effects of NE on ß1-, ß2-, ß3-, and {alpha}2A-AR mRNA levels and ß3- and {alpha}2A-AR protein levels in cultures of brown adipocytes. Differentiated brown adipocytes (d 7 in culture) were treated for 6 h with the indicated concentrations of NE. Total RNA was isolated and analyzed as described in Materials and Methods. mRNA levels were calculated as the ratio of signal intensity for the target genes relative to that for ß-actin, to correct for RNA. For the Western blots, 15 µg total protein was loaded. Developed Western blot nitrocellulose membranes were exposed to Hyperfilm ECL (Amersham) and quantified by scanner photodensitometry. Values were expressed as a percentage of nontreated cell samples, which were set to 100%. Data represent the means ± SEM of three separate experiments performed in duplicate. One-way ANOVA (P < 0.05): NE indicates NE effect. t test (P < 0.05): *, significant differences of NE-treated vs. non-NE-treated cells.

 
The effect of NE treatment on ß3-AR protein levels was dose dependent, and significantly down-regulated its levels at the highest concentration, although the drop was much lower compared with the mRNA. On the other hand, no down-regulation was observed on the levels of {alpha}2A-AR at any concentration used.

Therefore, the different AR subtypes were differentially modulated by NE in these cells, which is a fact physiologically important for the control of brown fat cell function.

Sex hormones have a direct and differential effect on AR gene expression
We have previously shown that sex hormones, mainly testosterone and progesterone, have opposite effects modulating UCP1 expression and lipid accumulation in brown adipocytes differentiated in culture (12).

To investigate whether these effects were mediated by changes in AR gene expression, differentiated brown adipocytes were treated with testosterone, 17ß-estradiol, and progesterone in serum-free medium for 24 h at concentrations from 10-9–10-7 M, because they are approximately physiological concentrations (22, 23). Results are shown in Table 1Go.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Effects of testosterone, 17ß-estradiol, and progesterone on ß1-, ß2-, ß3-, and {alpha}2A-AR mRNA levels in non-norepinephrine-treated and norepinephrine-treated cultures of brown adipocytes

 
Testosterone treatment produced an up-regulation in the mRNA levels for {alpha}2A-AR, as previously reported in white adipocytes (24, 25). On the other hand, both female sex hormones reduced mRNA levels for this receptor, and the effect was dose-dependent for progesterone.

An increase in ß1-AR mRNA levels was produced with all the sex hormones tested, although in different magnitude, and progesterone had the greatest stimulatory effect.

Both testosterone and 17ß-estradiol decreased ß2-AR mRNA levels, whereas progesterone showed a tendency to increase mRNA levels for this receptor.

The female sex hormones showed stimulatory effects on ß3-AR mRNA levels, which were stronger for progesterone, whereas no effect was seen after testosterone treatment.

Next, we investigated whether sex hormone effects on AR expression were maintained after stimulating brown adipocytes with NE 10-7 M for 6 h (see Table 1Go). For {alpha}2A-AR and ß3-AR, NE treatment gave a profile in testosterone, 17ß-estradiol, and progesterone-treated cells that was similar to that of the corresponding non-NE-treated cells. However, lower mRNA levels were observed (because of the NE regulation), particularly for ß3-AR. The down-regulating effects on ß2-AR mRNA levels by testosterone and 17ß-estradiol were reduced when NE was used. With regard to ß1-AR, only 17ß-estradiol in combination with NE appeared to have an effect on mRNA levels, reducing significantly its levels at 10-8 M.

On the whole, these results provide evidence that sex hormones have a direct and differential effect on AR expression. It is worth noticing that these effects were prevented when brown adipocytes where exposed at the same time to the transcriptional inhibitor, actinomycin D (1 µg/ml) (data not shown), suggesting a transcriptional mechanism for the sex hormone effects on adrenoceptor expression.

The differences found in some treatments between NE-treated and non-NE-treated cells, especially for ß1-AR and ß2-AR, could point toward a hormonal coordination in the brown adipocyte between NE and sex hormones, and the final effect may depend on the AR subtype.

Progesterone and 17ß-estradiol reduce {alpha}2A3-AR protein ratio
Because gender differences have been observed in the {alpha}2A3-AR protein ratio in BAT (6, 7), the influence of sex hormones on this ratio was also evaluated. Western blot analysis (Fig. 2Go) showed that 24 h treatments with progesterone and 17ß-estradiol were able to decrease the {alpha}2A3-AR ratio in differentiated brown adipocytes. In contrast, testosterone did not alter this ratio at any concentration tested, although an increase in {alpha}2A-AR and ß3-AR protein levels at lower doses was also observed (data not shown). It is worth emphasizing that the reduced {alpha}2A3-AR protein ratio for progesterone was due to an increase in ß3-AR protein together with a decrease in the {alpha}2A-AR (data not shown), whereas for 17ß-estradiol the effect was produced by an important decrease in the {alpha}2A-AR, results that were well correlated with above mRNA studies.



View larger version (21K):
[in this window]
[in a new window]
 
FIG. 2. Effects of testosterone, 17ß-estradiol, and progesterone on {alpha}2A3-AR protein ratio in cultures of brown adipocytes. For the Western-blots, 15 µg total protein was loaded. Developed Western blot nitrocellulose membranes were exposed to Hyperfilm ECL and quantified by scanner photodensitometry. Results were expressed as a percentage of the {alpha}2A and ß3-AR protein value of nontreated cell samples independently for both receptors, which were set to 100%, and then the ratio {alpha}2A3-AR was calculated. Data represent the means ± SEM of three separate experiments performed in duplicate. One-way ANOVA (P < 0.05): E, estradiol effect; P, progesterone effect. t test (P < 0.05): *, significant differences of hormone-treated vs. nontreated cells.

 
Lipolytic activity is differentially modulated by sex hormones
The influence of sex hormones on AR-mediated lipolysis was investigated in differentiated brown adipocytes, both basal and under stimulation with NE. Before the study with sex hormones, the lipolytic activity of brown adipocytes was studied with increasing doses of NE (Fig. 3AGo), obtaining the typical dose-response curve in the glycerol release to the culture medium, reaching maximal stimulation at 10-6 M. The 10-7 M concentration of NE was selected for the experiments with sex hormones because it brought about important glycerol levels in the medium without reaching saturated values.



View larger version (21K):
[in this window]
[in a new window]
 
FIG. 3. Differential effects of testosterone, 17ß-estradiol, and progesterone on lipolysis in cultures of brown adipocytes. A, Dose-response curve for the effects of NE on glycerol release in cultures of brown adipocytes. On d 7, after 24 h in the serum-free medium, brown adipocyte cultures were incubated for 6 h with the indicated concentrations of NE. At the end of the incubation period, medium was taken for glycerol determination as described in Materials and Methods. Values were expressed as a percentage of maximal glycerol release, which were set to 100%. Results are shown from a representative experiment. B and C, Sex hormone dose-response curves for lipolysis in brown adipocytes. On d 7, after 24 h treatment with sex hormones, brown adipocyte cultures were either nontreated or stimulated for 6 h with NE and without changing the medium. Results from non-NE-treated cells (B) and NE-treated cells (C) are shown. Values were expressed as a percentage of those obtained in the nonhormone and non-NE-treated cell samples, which were set to 100%. Data represent the means ± SEM of three separate experiments performed in duplicate. One-way ANOVA (P < 0.05): NE indicates NE effect, T indicates testosterone effect, P indicates progesterone effect. t test (P < 0.05): #, significant differences of hormone-treated vs. nontreated cells.

 
Testosterone, added to the culture medium, decreased basal lipolysis (Fig. 3BGo), with a significant effect at its highest concentration, 10-7 M. In contrast, neither 17ß-estradiol nor progesterone influenced basal lipolysis in the range of concentrations assayed.

After stimulating lipolysis for 6 h with NE (Fig. 3CGo), glycerol release was significantly reduced in testosterone-treated cells at all concentrations tested. Lipolysis stimulated by NE was enhanced with progesterone but was not significantly affected by 17ß-estradiol, although a tendency to increase glycerol was also observed.

To find out the involvement of the sex hormone receptors in the regulation of the lipolytic activity, the effect of the sex hormones was antagonized by specific agents: flutamide for testosterone, ICI 182.780 for 17ß-estradiol, and Mifepristone (RU486) for progesterone (Fig. 4Go). The inhibitory effect of testosterone on lipolysis was prevented when brown adipocytes were exposed at the same time to the androgen receptor antagonist flutamide. No effect on glycerol release was observed in 17ß-estradiol-treated cells or with the addition to the cells of ICI 182.780. The progesterone antagonist RU486 decreased basal lipolysis and did not reverse progesterone enhancement in NE-stimulated lipolysis. These effects observed with RU486 could be due to the fact that this antagonist acquires agonist activity in response to stimulation of cAMP signaling pathways and seems to be through the progesterone receptor, although RU486 can bind with high affinity to either progesterone receptor or glucocorticoid receptor (26).



View larger version (22K):
[in this window]
[in a new window]
 
FIG. 4. Effect of the sex hormone antagonists on lipolysis in cultures of brown adipocytes. The antagonists were: flutamide for testosterone (Flut), ICI 182.780 for 17ß-estradiol (ICI), and Mifepristone for progesterone (RU486). 0 indicates nonhormonal-treated cells (control); in the other groups, each hormone was tested at the concentration of 10-7 M, whereas a corresponding receptor antagonist (10-6 M) was added at the same time to an additional group of 10-7 M hormone-treated cells. Values were expressed as a percentage of those obtained in the nonhormone and non-NE-treated cell samples, which were set to 100%. Data represent the means ± SEM of three separate experiments performed in duplicate. One-way ANOVA (P < 0.05): NE indicates NE. t test (P < 0.05): *, significant differences of NE-treated vs. non-NE-treated cells. #, Significant differences of hormone-treated vs. nontreated cells.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Brown adipocytes, differentiated in primary culture and placed in serum-free medium, were found to be a suitable model for studying the effects of NE and sex hormones on AR gene expression, because these cells expressed the different adrenoceptor subtypes ({alpha}2A-, ß1-, ß2-, and ß3-AR).

Adrenergic receptor subtypes displayed a differential regulation by NE, i.e. up-regulation for ß1-AR and down-regulation for {alpha}2A-, ß2-, and ß3-AR. The marked down-regulation in ß3-AR mRNA levels found with NE treatment is consistent with the fact that ß3-AR expression regulation occurs only at a transcriptional level (21), because this adrenoceptor lacks consensus sequences for phosphorylation, unlike ß1-AR and ß2-AR (27), and is not regulated by desensitization. This dramatic down-regulation contrasted with the less marked regulation of {alpha}2A-AR and ß2-AR mRNA levels by NE. The differences in adrenoceptor regulation by NE could be due to the kind of mechanism involved. For instance, a suppression of transcription is the mechanism responsible for ß3-AR down-regulation; whereas, for ß2-AR, it is caused by an increase in mRNA degradation (28).

It is worth pointing out that NE exerted less pronounced effects on ß3-AR and {alpha}2A-AR protein levels than on their mRNA levels. These differences could indicate that longer stimulation times with NE would be necessary to appreciate greater changes, because adrenergic regulation of the gene expression for the different adrenoceptors has been shown to be both concentration and time dependent (19). In this sense, it has been reported that the half-life of the human ß3-AR in a heterologous expression system (murine L cells) is about 18 h and also that there is a lack of agonist-induced degradation of this protein (29), supporting again the hypothesis that the down-regulation of this receptor results mostly from the regulation of ß3-AR mRNA levels.

Under our experimental conditions, testosterone behaved as an antilipolytic hormone, and some of the effects could be mediated by an increase in {alpha}2A-AR mRNA and protein levels. The transcriptional regulation of {alpha}2A-AR by testosterone has been described to be androgen receptor dependent and limited to adipocytes (24, 25). Moreover, testosterone treatment brought about a lower lipolysis activation, both without NE and under stimulation with NE. These results would point toward a direct regulation of lipolysis by this hormone, and this would be mediated by the androgen receptor, because the testosterone effect on lipolysis was completely suppressed in the presence of flutamide. The inhibition of lipolytic activity by testosterone was found at almost all doses used, whereas the increase observed in the expression of {alpha}2A-AR was found only at some doses; thus, an effect of this hormone at other levels of the adrenergic pathway could not be discarded, as proposed in other studies on protein kinase A and hormone-sensitive lipase activity (30, 31, 32). Furthermore, in white adipocytes, androgens have been reported to have both inhibitory (i.e. up-regulation of {alpha}2A-AR) and stimulatory (i.e. enhancement of the adenylate cyclase activity, or up-regulation of ß-ARs) effects on lipolytic activity (32). As a consequence, it could be argued that the final effect for testosterone would be dependent both on the fat depot and on the experimental conditions used (in vivo vs. in vitro). It seems that in brown adipocytes and under our experimental conditions, the inhibitory pathway on lipolysis after testosterone treatment is the one to prevail.

In a previous report, we have observed in the same experimental model an antiadipogenic effect of testosterone, with cells showing fewer and smaller lipid droplets than control ones, and a decrease in UCP1 mRNA levels, which is a differentiation marker (12). The increase in {alpha}2A-AR expression found after testosterone treatment would lead to a lower activation of lipolysis and thermogenesis, which could also account for the testosterone-dependent inhibition mechanism of UCP1 mRNA expression.

In opposition to androgens, female sex hormones have been shown, by some studies (33), to behave as proadipogenic hormones. Moreover, a previous work with brown adipocyte cell cultures showed that cells treated with 17ß-estradiol and progesterone have more and larger lipid droplets, leading to an apparently more differentiated morphology (12). In this work, the female sex hormones had stimulatory effects on the expression of ß3-AR and inhibitory effects on the expression of {alpha}2A-AR, and resulted in a lower {alpha}2A3-AR protein ratio. This would lead to a higher cAMP accumulation and, as a result, a greater activation of lipolysis and thermogenesis (the latter through an increase in UCP1 expression), as commented above. This behavior was more marked for progesterone, where higher glycerol levels were observed in the medium after NE treatment, and which correlates with greater UCP1 mRNA levels, reported in the same model (12). However, the changes obtained in AR expression induced by 17ß-estradiol were not great enough to stimulate this double axis (lipolysis-thermogenesis). Our findings are consistent with a report demonstrating that oleoyl-estrone increases ß3-AR mRNA expression and the cAMP response to isoprotenerol in BAT, indicating that the adrenergic pathway is modulated by oleoyl-estrone at the level of AR gene expression and cAMP accumulation as well (34).

Nevertheless, there seem to be conflicting results on the effects of female sex hormones on BAT in vivo studies. On the one hand, many studies support the notion that estrogen increases energy expenditure (35, 36, 37). Moreover, estrogen deficiency is followed by a reduced UCP1 expression in BAT (38); and additionally, it has been shown that estrogen receptor knockout mice have a decrease in thermogenesis (39). In contrast, other reports assert that 17ß-estradiol and progesterone inhibit BAT thermogenesis (40, 41), and change the affinity or density of ARs (42). From the present study, it seems to be clear that sex hormones can modulate the expression of AR in cultured brown adipocytes, and differences in vivo, compared with in vitro, could indicate a role for the sympathetic nervous system or changes in other hormones/metabolites.

As commented previously, gender differences have been reported in vivo in the thermogenic response of BAT (6, 10, 11, 12). Hence, female rats under usual housing temperature (22 C) have a more recruited BAT with a higher multilocular arrangement, greater mitochondrial machinery, and a higher thermogenic activity and capacity (7). This fact is accompanied by a lesser presence of {alpha}2A-AR in females and also a lower {alpha}2A3-AR ratio (6, 7). In view of our findings, the gender differences found in vivo in this tissue could be dependent, at least in part, on the direct action of the sex hormones. Besides, the recruitment process, both in vivo and in vitro, is known to be mainly regulated by NE (9). In this sense, gender differences in NE release in BAT could not be ruled out either as determining factors for the recruitment differences found in vivo (43). However, in contrast with the recruitment process in vivo (where brown adipocytes are always under some degree of adrenergic stimulation), in vitro experiments avoid the influence of the sympathetic nervous system (44). Therefore, although NE is the trigger for the recruitment process, sex hormones could also influence it through a direct effect on the adrenergic control of brown adipocytes, by modulating both thermogenesis and lipolysis. Thus, our findings provide support for a role of the main sex hormones, as a part of the hormonal environment, in the recruitment process of BAT.


    Acknowledgments
 
We thank Dr. F. García, Dra. M. Gianotti, Dra. I. Lladó, Dra. A. M. Proenza, and Dr. J. Oliver for critical reading of the manuscript.


    Footnotes
 
This work was supported by the Spanish Government (Grants BFI 2000-0988-04 and FIS 01/1379) and by the European Commission (COST Action 918). M.M. was supported by a grant of the University of the Balearic Islands, and A.M.R. was supported by a grant of the Spanish Government.

Abbreviations: AR, Adrenergic receptor; BAT, brown adipose tissue; DMSO, dimethylsulfoxide; NE, norepinephrine; UCP1, uncoupling protein 1.

Received April 28, 2003.

Accepted for publication July 14, 2003.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Lowell BB, Spiegelman BM 2000 Towards a molecular understanding of adaptive thermogenesis. Nature 404:652–660[Medline]
  2. Nedergaard J, Golozoubova V, Matthias A, Asadi A, Jacobsson A, Cannon B 2001 UCP1: the only protein able to mediate adaptive non-shivering thermogenesis and metabolic inefficiency. Biochim Biophys Acta 1504:82–106[Medline]
  3. Lafontan M, Barbe P, Galitzky J, Tavernier G, Langin D, Carpene C, Bousquet-Melou A, Berlan M 1997 Adrenergic regulation of adipocyte metabolism. Hum Reprod 12(Suppl 1):6–20
  4. Giacobino JP 1995 ß3-Adrenoceptor: an update. Eur J Endocrinol 132:377–385[Medline]
  5. Lafontan M, Berlan M 1995 Fat cell {alpha} 2-adrenoceptors: the regulation of fat cell function and lipolysis. Endocr Rev 16:716–738[CrossRef][Medline]
  6. Rodriguez E, Monjo M, Rodriguez-Cuenca S, Pujol E, Amengual B, Roca P, Palou A 2001 Sexual dimorphism in the adrenergic control of rat brown adipose tissue response to overfeeding. Pflugers Arch 442:396–403[CrossRef][Medline]
  7. Rodriguez-Cuenca S, Pujol E, Justo R, Frontera M, Oliver J, Gianotti M, Roca P 2002 Sex-dependent thermogenesis. Differences in mitochondrial morphology and function, and adrenergic response in bat. J Biol Chem 277:42958–42963[Abstract/Free Full Text]
  8. Herron D, Rehnmark S, Nechad M, Loncar D, Cannon B, Nedergaard J 1990 Norepinephrine-induced synthesis of the uncoupling protein thermogenin (UCP) and its mitochondrial targeting in brown adipocytes differentiated in culture. FEBS Lett 268:296–300[CrossRef][Medline]
  9. Cannon B, Jacobsson A, Rehnmark S, Nedergaard J 1996 Signal transduction in brown adipose tissue recruitment: noradrenaline and beyond. Int J Obes Relat Metab Disord 20(Suppl 3):S36–S42
  10. Quevedo S, Roca P, Pico C, Palou A 1998 Sex-associated differences in cold-induced UCP1 synthesis in rodent brown adipose tissue. Pflugers Arch 436:689–695[CrossRef][Medline]
  11. Roca P, Rodriguez AM, Oliver P, Bonet ML, Quevedo S, Pico C, Palou A 1999 Brown adipose tissue response to cafeteria diet-feeding involves induction of the UCP2 gene and is impaired in female rats as compared to males. Pflugers Arch 438:628–634[CrossRef][Medline]
  12. Rodriguez AM, Monjo M, Roca P, Palou A 2002 Opposite actions of testosterone and progesterone on UCP1 mRNA expression in cultured brown adipocytes. Cell Mol Life Sci 59:1714–1723[CrossRef][Medline]
  13. Dieudonne MN, Pecquery R, Boumediene A, Leneveu MC, Giudicelli Y 1998 Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. Am J Physiol 274:C1645–C1652
  14. Mizutani T, Nishikawa Y, Adachi H, Enomoto T, Ikegami H, Kurachi H, Nomura T, Miyake A 1994 Identification of estrogen receptor in human adipose tissue and adipocytes. J Clin Endocrinol Metab 78:950–954[Abstract]
  15. O’Brien SN, Welter BH, Mantzke KA, Price TM 1998 Identification of progesterone receptor in human subcutaneous adipose tissue. J Clin Endocrinol Metab 83:509–513[Abstract/Free Full Text]
  16. Nechad M, Kuusela P, Carneheim C, Bjorntorp P, Nedergaard J, Cannon B 1983 Development of brown fat cells in monolayer culture. I. Morphological and biochemical distinction from white fat cells in culture. Exp Cell Res 149:105–118[CrossRef][Medline]
  17. Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685[CrossRef][Medline]
  18. Puigserver P, Llado I, Palou A, Gianotti M 1991 Evidence for masking of brown adipose tissue mitochondrial GDP-binding sites in response to fasting in rats made obese by dietary manipulation. Effects of reversion to standard diet. Biochem J 279:575–579
  19. Bengtsson T, Cannon B, Nedergaard J 2000 May Differential adrenergic regulation of the gene expression of the ß-adrenoceptor subtypes ß1, ß2 and ß3 in brown adipocytes. J Biochem 347:643–651[CrossRef]
  20. Bengtsson T, Redegren K, Strosberg AD, Nedergaard J, Cannon B 1996 Down-regulation of ß3 adrenoreceptor gene expression in brown fat cells is transient and recovery is dependent upon a short-lived protein factor. J Biol Chem 271:33366–33375[Abstract/Free Full Text]
  21. Granneman JG, Lahners KN 1995 Regulation of mouse ß 3-adrenergic receptor gene expression and mRNA splice variants in adipocytes. Am J Physiol 268:C1040–C1044
  22. Vanderschueren D, Vandenput L, Boonen S, Van Herck E, Swinnen JV, Bouillon R 2000 An aged rat model of partial androgen deficiency: prevention of both loss of bone and lean body mass by low-dose androgen replacement. Endocrinology 141:1642–1647[Abstract/Free Full Text]
  23. Lu CC, Tsai SC, Wang SW, Tsai CL, Lau CP, Shih HC, Chen YH, Chiao YC, Liaw C, Wang PS 1998 Effects of ovarian steroid hormones and thyroxine on calcitonin secretion in pregnant rats. Am J Physiol 274:E246–E252
  24. Bouloumie A, Valet P, Dauzats M, Lafontan M, Saulnier-Blache JS 1994 In vivo up-regulation of adipocyte {alpha} 2-adrenoceptors by androgens is consequence of direct action on fat cells. Am J Physiol 267:C926–C931
  25. Pecquery R, Dieudonne MN, Cloix JF, Leneveu MC, Dausse JP, Giudicelli Y 1995 Enhancement of the expression of the {alpha} 2-adrenoreceptor protein and mRNA by a direct effect of androgens in white adipocytes. Biochem Biophys Res Commun 206:112–118[CrossRef][Medline]
  26. Beck CA, Weigel NL, Moyer ML, Nordeen SK, Edwards DP 1993 The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. Proc Natl Acad Sci USA 90:4441–4445[Abstract/Free Full Text]
  27. Carpene C, Galitzky J, Collon P, Esclapez F, Dauzats M, Lafontan M 1993 Desensitization of ß-1 and ß-2, but not ß-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion. J Pharmacol Exp Ther 265:237–247[Abstract/Free Full Text]
  28. Hadcock JR, Wang HY, Malbon CC 1989 Agonist-induced destabilization of ß-adrenergic receptor mRNA. Attenuation of glucocorticoid-induced up-regulation of ß-adrenergic receptors. J Biol Chem 264:19928–19933[Abstract/Free Full Text]
  29. Nantel F, Marullo S, Krief S, Strosberg AD, Bouvier M 1994 Cell-specific down-regulation of the ß 3-adrenergic receptor. J Biol Chem 269:13148–13155[Abstract/Free Full Text]
  30. Xu XF, De Pergola G, Bjorntorp P 1991 Testosterone increases lipolysis and the number of ß-adrenoceptors in male rat adipocytes. Endocrinology 128:379–382[Abstract]
  31. Xu X, De Pergola G, Eriksson PS, Fu L, Carlsson B, Yang S, Eden S, Bjorntorp P 1993 Postreceptor events involved in the up-regulation of ß-adrenergic receptor mediated lipolysis by testosterone in rat white adipocytes. Endocrinology 132:1651–1657[Abstract]
  32. Giudicelli Y, Dieudonne MN, Lacasa D, Pasquier YN, Pecquery R 1993 Modulation by sex hormones of the membranous transducing system regulating fatty acid mobilization in adipose tissue. Prostaglandins Leukot Essent Fatty Acids 48:91–100[CrossRef][Medline]
  33. Dieudonne MN, Pecquery R, Leneveu MC, Giudicelli Y 2000 Opposite effects of androgens and estrogens on adipogenesis in rat preadipocytes: evidence for sex and site-related specificities and possible involvement of insulin-like growth factor 1 receptor and peroxisome proliferator-activated receptor {gamma}2. Endocrinology 141:649–656[Abstract/Free Full Text]
  34. Cabot C, del Mar Grasa M, Fernandez-Lopez JA, Alemany M 2001 Effect of oleoyl-estrone treatment on the expression of ß1-, ß2-, and ß3-adrenoreceptors in rat adipose tissues. Mol Cell Biochem 221:109–115[CrossRef][Medline]
  35. Laudenslager ML, Wilkinson CW, Carlisle HJ, Hammel HT 1980 Energy balance in ovariectomized rats with and without estrogen replacement. Am J Physiol 238:R400–R405
  36. Laudenslager ML, Carlisle HJ, Calvano SE 1982 Increased heat loss in ovariectomized hypothyroid rats treated with estradiol. Am J Physiol 243:R70–R76
  37. Bartness TJ, Wade GN 1984 Effects of interscapular brown adipose tissue denervation on body weight and energy metabolism in ovariectomized and estradiol-treated rats. Behav Neurosci 98:674–685[CrossRef][Medline]
  38. Pedersen SB, Bruun JM, Kristensen K, Richelsen B 2001 Regulation of UCP1, UCP2, and UCP3 mRNA expression in brown adipose tissue, white adipose tissue, and skeletal muscle in rats by estrogen. Biochem Biophys Res Commun 288:191–197[CrossRef][Medline]
  39. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS 2000 Increased adipose tissue in male and female estrogen receptor-{alpha} knockout mice. Proc Natl Acad Sci USA 97:12729–12734[Abstract/Free Full Text]
  40. Puerta M, Abelenda M, Nava MP, Fernandez A 1993 Reduced noradrenaline responsiveness of brown adipocytes isolated from estradiol-treated rats. Can J Physiol Pharmacol 71:858–861[Medline]
  41. Abelenda M, Castro C, Venero C, Puerta M 1994 Reduced oxygen consumption of brown adipocytes isolated from progesterone-treated rats. Can J Physiol Pharmacol 72:1226–1230[Medline]
  42. Malo A, Puerta M 2001 Oestradiol and progesterone change ß3-adrenergic receptor affinity and density in brown adipocytes. Eur J Endocrinol 145:87–91[Abstract]
  43. McDonald RB, Hamilton JS, Horwitz BA 1993 Influence of age and gender on brown adipose tissue norepinephrine turnover. Proc Soc Exp Biol Med 204:117–121[Abstract]
  44. Cannon B, Nedergaard J 1996 Adrenergic regulation of brown adipocyte differentiation. Biochem Soc Trans 24:407–412[Medline]



This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Harslund, O. L. Nielsen, N. Brunner, and H. Offenberg
Gender-dependent physiological implications of combined PAI-1 and TIMP-1 gene deficiency characterized in a mouse model
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1630 - R1639.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Rodriguez-Cuenca, M. Monjo, M. Gianotti, A. M. Proenza, and P. Roca
Expression of mitochondrial biogenesis-signaling factors in brown adipocytes is influenced specifically by 17beta-estradiol, testosterone, and progesterone
Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E340 - E346.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Monjo, E. Pujol, and P. Roca
{alpha}2- to {beta}3-Adrenoceptor switch in 3T3-L1 preadipocytes and adipocytes: modulation by testosterone, 17{beta}-estradiol, and progesterone
Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E145 - E150.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Blanchette, K. Blouin, C. Richard, P. Dupont, V. Luu-The, and A. Tchernof
Expression and Activity of 20{alpha}-Hydroxysteroid Dehydrogenase (AKR1C1) in Abdominal Subcutaneous and Omental Adipose Tissue in Women
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 264 - 270.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Rodriguez-Cuenca, M. Monjo, A. M. Proenza, and P. Roca
Depot differences in steroid receptor expression in adipose tissue: possible role of the local steroid milieu
Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E200 - E207.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
144/11/4923    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Monjo, M.
Right arrow Articles by Roca, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monjo, M.
Right arrow Articles by Roca, P.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals